Athenex Inc
NASDAQ: atnx
$1.57
USD
+$0.09
+6.08%
Prev Close
$1.48
Today's Open
$1.46
Volume
1.62M
Market Cap
171.63M
Day Range
52W Range
Overview
Athenex, Inc., a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of drugs for the treatment of cancer. The company is headquartered in Buffalo, New York.
Read moreCurrent Price
15 min delay
Market Trend
SPDR S&P 500
Sector Trend
Healthcare
Sentiment
(beta)
Insufficient Data
Ratios
Valuation Ratios
EPS (TTM)
-1.45
P/E Ratio
0
Price to Sales
1.429
Price to Book
1.101
Profit Ratios
Profit Margin
-123.80%
EBITDA Margin
-121.87%
Net Profit Margin
41.89%
ROA
-21.00%
Total Revenue
$117.05M
Net Profit
$49.04M
EV to EBITDA
0
EV to Revenue
2.026